10x Genomics Inc. (TXG)

7.97

-0.88 (-9.94%)

At close: Apr 03, 2025, 3:59 PM

7.96

-0.13%

After-hours: Apr 03, 2025, 06:52 PM EDT

10x Genomics Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-182.63M	-255.1M	-166M	-58.22M	-542.73M	-31.25M	-112.48M	-18.76M
Depreciation & Amortization	43.71M	43.62M	33.01M	28.25M	19.02M	7.07M	3.9M	4.3M
Stock-Based Compensation	140.75M	166.95M	136.85M	95.96M	48.63M	13.33M	2.66M	1.66M
Other Working Capital	-12.57M	26.1M	-5.13M	-34.36M	-10.16M	51.85M	43.91M	6.04M
Other Non-Cash Items	3.58M	11.99M	1.96M	79K	306.02M	101K	1.25M	149K
Deferred Income Tax	n/a	n/a	n/a	n/a	1.55M	614K	251K	n/a
Change in Working Capital	1.25M	17.34M	-39.42M	-87.44M	-50.38M	44.76M	28.02M	1.95M
Operating Cash Flow	6.66M	-15.2M	-33.61M	-21.37M	-217.9M	34.63M	-76.41M	-10.7M
Capital Expenditures	-12.39M	-49.52M	-131.66M	-101.28M	-38.39M	-42.77M	-6.71M	-3.76M
Acquisitions	n/a	n/a	-4M	-5.45M	n/a	n/a	n/a	n/a
Purchase of Investments	-48.88M	n/a	-282.87M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	29.64M	183.02M	67.64M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-1M	-923K	-215.23M	n/a	-1.73M	-25K	-425K	n/a
Investing Cash Flow	-32.63M	133.49M	-350.89M	-106.73M	-38.39M	-42.77M	-6.71M	-3.76M
Debt Repayment	n/a	n/a	n/a	n/a	-37.1M	n/a	18.74M	-393K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-80K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	10.91M	13.67M	15.82M	35.3M	23.74M	3.77M	1.8M	1.09M
Financial Cash Flow	10.91M	13.67M	15.82M	35.3M	468.91M	414.59M	105.37M	20.58M
Net Cash Flow	-15.22M	131.93M	-368.72M	-92.57M	212.15M	406.4M	22.23M	6.11M
Free Cash Flow	-5.73M	-64.72M	-165.27M	-122.65M	-256.29M	-8.14M	-83.12M	-14.46M